Back to search

Article

Identifying Advanced Esophageal Squamous Cell Carcinoma Patients Who Benefit from Immunotherapy Maintenance Following Immunotherapy and Radiotherapy: A Multicenter Study

2026-02-02

Abstract excerpt

<title>Abstract</title> <p>Objective Patients with advanced esophageal squamous cell carcinoma (ESCC) who have received first-line immunotherapy and radiotherapy remain uncertain as to which individuals may benefit from immunotherapy maintenance. This study aims to establish a deep learning model based on interactive automated 3D segmentation to predict immunotherapy + radiotherapy efficacy and identify patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8db8458d-7895-5379-ac7e-d749a6264ff0
DOI
10.21203/rs.3.rs-8639357/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identifying Advanced Esophageal Squamous Cell Carcinoma Patients Who Benefit from Immunotherapy Maintenance Following Immunotherapy and Radiotherapy: A Multicenter StudyDOI 10.21203/rs.3.rs-8639357/v1
Select a neighboring publication to make it the new centre.